These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26338962)

  • 1. A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme.
    Galore-Haskel G; Nemlich Y; Greenberg E; Ashkenazi S; Hakim M; Itzhaki O; Shoshani N; Shapira-Fromer R; Ben-Ami E; Ofek E; Anafi L; Besser MJ; Schachter J; Markel G
    Oncotarget; 2015 Oct; 6(30):28999-9015. PubMed ID: 26338962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR1-mediated regulation of melanoma invasion.
    Nemlich Y; Baruch EN; Besser MJ; Shoshan E; Bar-Eli M; Anafi L; Barshack I; Schachter J; Ortenberg R; Markel G
    Nat Commun; 2018 May; 9(1):2154. PubMed ID: 29855470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
    Nemlich Y; Greenberg E; Ortenberg R; Besser MJ; Barshack I; Jacob-Hirsch J; Jacoby E; Eyal E; Rivkin L; Prieto VG; Chakravarti N; Duncan LM; Kallenberg DM; Galun E; Bennett DC; Amariglio N; Bar-Eli M; Schachter J; Rechavi G; Markel G
    J Clin Invest; 2013 Jun; 123(6):2703-18. PubMed ID: 23728176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
    Shoshan E; Mobley AK; Braeuer RR; Kamiya T; Huang L; Vasquez ME; Salameh A; Lee HJ; Kim SJ; Ivan C; Velazquez-Torres G; Nip KM; Zhu K; Brooks D; Jones SJ; Birol I; Mosqueda M; Wen YY; Eterovic AK; Sood AK; Hwu P; Gershenwald JE; Robertson AG; Calin GA; Markel G; Fidler IJ; Bar-Eli M
    Nat Cell Biol; 2015 Mar; 17(3):311-21. PubMed ID: 25686251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAR1p150 regulates the biosynthesis and function of miRNA-149* in human melanoma.
    Yujie Ding MM; Shi X; Ji J; Su Y
    Biochem Biophys Res Commun; 2020 Mar; 523(4):900-907. PubMed ID: 31959472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
    Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
    J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.
    Karki R; Sundaram B; Sharma BR; Lee S; Malireddi RKS; Nguyen LN; Christgen S; Zheng M; Wang Y; Samir P; Neale G; Vogel P; Kanneganti TD
    Cell Rep; 2021 Oct; 37(3):109858. PubMed ID: 34686350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.
    Margolis N; Moalem H; Meirson T; Galore-Haskel G; Markovits E; Baruch EN; Vizel B; Yeffet A; Kanterman-Rifman J; Debby A; Besser MJ; Schachter J; Markel G
    Cancer Immunol Res; 2022 Sep; 10(9):1127-1140. PubMed ID: 35731225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner.
    Liu Q; Huang CS; Chen S; Zhu YQ; Huang XT; Zhao GY; Xu QC; Shi YH; Li W; Wang R; Yin XY
    Cell Prolif; 2024 Oct; 57(10):e13659. PubMed ID: 38773866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
    de Santiago PR; Blanco A; Morales F; Marcelain K; Harismendy O; Sjöberg Herrera M; Armisén R
    Life Sci; 2021 Mar; 268():118956. PubMed ID: 33383047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ADAR1 induces ferroptosis of breast cancer cells.
    Yin C; Zhang MM; Wang GL; Deng XY; Tu Z; Jiang SS; Gao ZD; Hao M; Chen Y; Li Y; Yang SY
    Cell Signal; 2024 Sep; 121():111258. PubMed ID: 38866351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
    J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
    Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
    Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin regulates the expression of MMP14 and ADAR1 through EIF2AK2 signaling to promote the proliferation and progression of malignant melanoma cells.
    Liang L; Wang J; Guo T; Huang L; Wu Y; Xu R; Huang T; Ma B
    Neoplasma; 2024 Apr; 71(2):180-192. PubMed ID: 38766853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding.
    Wang Q; Hui H; Guo Z; Zhang W; Hu Y; He T; Tai Y; Peng P; Wang L
    RNA; 2013 Nov; 19(11):1525-36. PubMed ID: 24067935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.